Flexion Therapeutics: 3Q Earnings Snapshot

November 7, 2018

BURLINGTON, Mass. (AP) _ Flexion Therapeutics Inc. (FLXN) on Wednesday reported a loss of $43.6 million in its third quarter.

The Burlington, Massachusetts-based company said it had a loss of $1.15 per share.

The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.24 per share.

The specialty pharmaceutical companies that specializes in pain relief posted revenue of $7 million in the period, also exceeding Street forecasts. Four analysts surveyed by Zacks expected $5.9 million.

Flexion Therapeutics shares have fallen 43 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $14.27, a fall of 40 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FLXN at https://www.zacks.com/ap/FLXN

Update hourly